Dr. Darrin Morrissey:

We are maintaining the 10% of our budget dedicated to CTI and the 20% across cancer research in general. We are working actively with the Department on pushing particular priority angles. Clinical research more broadly, including clinical research facilities and infrastructure, is one of the areas where we are in active discussion with the Department.